Section: Jersey City Medical Center News

New Procedure Performed at Jersey City Medical Center – Barnabas Health Affords Protection Against Cardiac Arrest


The implant of a subcutaneous defibrillator (or S-ICD) recently gave a 68-year-old Jersey City man peace of mind that should he go into sudden cardiac arrest (SCA), the device will protect him – without the risks previously associated with a traditional defibrillator.

In a one-hour procedure in the Electrophysiology Lab at Jersey City Medical Center – Barnabas Health, the man – while under “conscious sedation” – became was one of the first patients in the New York metropolitan area to have an S-ICD implanted.

“It went very smoothly,” said Dr. Roy Sauberman, Director of Cardiac Electrophysiology at Jersey City Medical Center, who performed the procedure. “The patient was resting comfortably and returned home the following day.”

Sudden Cardiac Arrest

SCA is an abrupt loss of heart function. Most episodes are caused by the rapid and/or chaotic activity of the heart known as ventricular tachycardia or ventricular fibrillation. It is estimated that 850,000 Americans are at risk of this potentially fatal condition and in need of a defibrillator, but remain unprotected.

SCA the largest cause of natural death in the U.S., causing about 325,000 adult deaths in the U.S. each year, and is responsible for half of all heart disease deaths.

It is not a heart attack (myocardial infarction), but can occur during a heart attack. A heart attack occurs when there is a blockage in one or more of the arteries to the heart, preventing the heart from receiving enough oxygen-rich blood. If the oxygen in the blood cannot reach the heart muscle, the heart becomes damaged.

In contrast, SCA occurs when the electrical system to the heart malfunctions and suddenly becomes very irregular. The heart beats dangerously fast. The ventricles may flutter or quiver (ventricular fibrillation), and blood is not delivered to the body. In the first few minutes, the greatest concern is that blood flow to the brain will be reduced so drastically that the person will lose consciousness. Death follows unless emergency treatment is begun immediately.

A New Device

According to Dr. Sauberman, the S-ICD system is designed to provide the same protection from SCA as traditional transvenous implantable cardioverter defibrillators. However, the S-ICD sits below the skin without the need for thin, insulated wires known as leads. With the traditional ICD, these leads are attached inside the heart chambers in order to conduct the charge. As a result, the S-ICD device avoids potential risks of puncturing the lung or the heart, major bleeding, or blood-borne infections.

With the new device, such risks as puncturing the lung or the heart, or introducing bacteria that could cling to the defibrillator and cause a serious infection are avoided.

Dr. Sauberman and the patient’s cardiologist both felt that the man was a good candidate for the surgery because he was at greater risk for sudden cardiac disease due to his weakened heart muscle following a heart attack.

“A defibrillator offers an insurance plan for those heart patients who are at risk of SCA,” said Dr. Sauberman. “The new device should become the option of choice for many qualified patients as it offers that same protection, doing its job silently, while providing far less risk.”

Categories: Press Releases